Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2002, p. 1125-1127, Vol. 46, No. 4
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.4.1125-1127.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Faculty of Tropical Medicine,1 Department of Pharmacology, Faculty of Pharmacy Mahidol University,6 Mahidol University, Shoklo Malaria Research Unit,3 Mae Sot Hospital, Mae Sot, Tak Province,7 Department of Immunology and Medicine, Armed Forces Research Institute of Medical Sciences,5 Department of Medicine, Siriraj Hospital, Bangkok, Thailand,8 Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom,2 Academic Medical Centre, Amsterdam, The Netherlands4
Received 8 September 2000/ Returned for modification 29 January 2001/ Accepted 23 November 2001
Plasma antimalarial activity following oral artesunate or dihydroartemisinin (DHA) treatment was measured by a bioassay in 18 patients with uncomplicated falciparum malaria. The mean antimalarial activity in terms of the bioavailability of DHA relative to that of artesunate did not differ significantly from 1, suggesting that DHA can be formulated to be an acceptable oral alternative to artesunate.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»